InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
DMRA
Result 22 decisions over 120 months
Reset filters
Direction ?
Both22 Bought0 Sold22
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: DMRA Plan: Discretionary
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
DMRA Damora Therapeutics, Inc.
6 Jul 2026
Winslow Garrett
General Counsel
Sold at will
245
$7.35K
9.7%
DMRA Damora Therapeutics, Inc.
2 Jan 2026
Schambye Hans T.
Chief Executive Officer
Sold at will
700
$14.97K
13.0%
DMRA Damora Therapeutics, Inc.
2 Jan 2026
Winslow Garrett
General Counsel
Sold at will
255
$5.45K
12.1%
DMRA Damora Therapeutics, Inc.
2 Jan 2026
Firmani Lori
Chief Financial Officer
Sold at will
135
$2.89K
12.7%
DMRA Damora Therapeutics, Inc.
3 Jul 2025
Schambye Hans T.
Chief Executive Officer
Sold at will
735
$2.48K
15.5%
DMRA Damora Therapeutics, Inc.
3 Jul 2025
Winslow Garrett
General Counsel
Sold at will
260
$881.40
15.4%
DMRA Damora Therapeutics, Inc.
3 Jul 2025
Firmani Lori
Interim CFO
Sold at will
147
$498.33
17.5%
DMRA Damora Therapeutics, Inc.
3 Jan 2025
Schambye Hans T.
Chief Executive Officer
Sold at will
1,341
$7.51K
28.3%
DMRA Damora Therapeutics, Inc.
3 Jan 2025
Winslow Garrett
General Counsel
Sold at will
471
$2.64K
31.8%
DMRA Damora Therapeutics, Inc.
3 Jan 2025
Firmani Lori
Interim CFO
Sold at will
261
$1.47K
36.0%
DMRA Damora Therapeutics, Inc.
15 Aug 2023
ORBIMED ADVISORS LLC
10% owner indirect
Sold at will 3×
822,680
$617.01K
89.4%
DMRA Damora Therapeutics, Inc.
31 Jul 2023
ORBIMED ADVISORS LLC
10% owner indirect
Sold at will 3×
209,400
$628.20K
60.7%
DMRA Damora Therapeutics, Inc.
25 Jul 2023
ORBIMED ADVISORS LLC
10% owner indirect
Sold at will 3×
39,200
$114.46K
19.5%
DMRA Damora Therapeutics, Inc.
13 Jul 2023
ORBIMED ADVISORS LLC
10% owner indirect
Sold at will 3×
194,700
$467.28K
53.4%
DMRA Damora Therapeutics, Inc.
17 Apr 2023
ORBIMED ADVISORS LLC
10% owner indirect
Sold at will 3×
13,089
$25.79K
6.8%
DMRA Damora Therapeutics, Inc.
14 Apr 2023
ORBIMED ADVISORS LLC
10% owner indirect
Sold at will 3×
41,446
$77.09K
18.7%
DMRA Damora Therapeutics, Inc.
13 Apr 2023
ORBIMED ADVISORS LLC
10% owner indirect
Sold at will 3×
13,946
$25.38K
7.1%
DMRA Damora Therapeutics, Inc.
12 Apr 2023
ORBIMED ADVISORS LLC
10% owner indirect
Sold at will 3×
2,363
$4.28K
1.3%
DMRA Damora Therapeutics, Inc.
11 Apr 2023
ORBIMED ADVISORS LLC
10% owner indirect
Sold at will 3×
13,946
$25.38K
7.1%
DMRA Damora Therapeutics, Inc.
10 Apr 2023
ORBIMED ADVISORS LLC
10% owner indirect
Sold at will 3×
51,228
$91.70K
21.6%
DMRA Damora Therapeutics, Inc.
6 Apr 2023
ORBIMED ADVISORS LLC
10% owner indirect
Sold at will 3×
9,665
$19.33K
4.9%
DMRA Damora Therapeutics, Inc.
5 Apr 2023
ORBIMED ADVISORS LLC
10% owner indirect
Sold at will 3×
92,965
$202.66K
33.2%
Showing 1–22 of 22.